Cargando…

Comparative analysis of plasma metabolomics markers in patients with major depressive disorder and healthy controls

INTRODUCTION: Mood disorders, including depression, are diseases associated with an increased risk of several metabolic alterations. Metabolomics studies have proved their potential for detecting novel biomarkers of psychiatric diseases. OBJECTIVES: To analyze the plasma metabolite profiling of pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Homorogan, C., Nitusca, D., Enatescu, V., Moraru, C., Socaciu, C., Marian, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567226/ http://dx.doi.org/10.1192/j.eurpsy.2022.835

Ejemplares similares

Untargeted Plasma Metabolomic Profiling in Patients with Major Depressive Disorder Using Ultra-High Performance Liquid Chromatography Coupled with Mass Spectrometry
por: Homorogan, Claudia, et al.
Publicado: (2021)

Telomere length from peripheral blood DNA in major depressive disorder: a case/control comparison and association with antidepressant treatment response
por: Kalinovic, R., et al.
Publicado: (2023)

Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators
por: Homorogan, Claudia, et al.
Publicado: (2021)

Distribution of microRNAs associated with major depressive disorder among blood compartments
por: Homorogan, Claudia, et al.
Publicado: (2021)

Circulating Plasma Micro RNAs in Patients with Major Depressive Disorder Treated with Antidepressants: A Pilot Study
por: Enatescu, Virgil Radu, et al.
Publicado: (2016)

Potential Diagnostic Biomarker Detection for Prostate Cancer Using Untargeted and Targeted Metabolomic Profiling
por: Nitusca, Diana, et al.
Publicado: (2023)

Sociodemographic, personality and symptomatologic profiles associated with an increased likelihood of suicidal risk in patients hospitalized for recurrent depressive disorders
por: Kalinovic, R., et al.
Publicado: (2021)

Osteoarthritis and microRNAs: Do They Provide Novel Insights into the Pathophysiology of This Degenerative Disorder?
por: Iulian Stanciugelu, Stefan, et al.
Publicado: (2022)

Atopic Dermatitis and Major Depressive Disorder: is there causality?
por: Reis, C. S., et al.
Publicado: (2023)

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
por: Du, Yue, et al.
Publicado: (2021)

rTMS efficacy in major depression disorder: comparing two reviews
por: Yasmine, S., et al.
Publicado: (2023)

Evaluation of plasma levels of BDNF in patients with disorder depressive
por: Galletta, D., et al.
Publicado: (2021)

Depression during the COVID-19 pandemic. A retrospective study on depressive disorders among psychiatric patients admitted at “elisabeta doamna” hospital galati, romania
por: Mihailov, O., et al.
Publicado: (2021)

Adolescent oral contraceptive use and future major depressive disorder
por: Wit, A. De, et al.
Publicado: (2021)

The Role of Base Excision Repair in Major Depressive Disorder and Bipolar Disorder
por: Kucuker, M., et al.
Publicado: (2022)

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
por: Gui, Si-Wen, et al.
Publicado: (2018)

The role of miRNA in diagnosing and clarifying the pathomechanisms in major depressive disorder
por: Ho, C. S., et al.
Publicado: (2023)

Mindfulness-based cognitive therapy for major depressive disorder- a literature review
por: Vasile, D., et al.
Publicado: (2021)

Brain aging in major depressive disorder
por: Han, L., et al.
Publicado: (2021)

quality of remission in the major depressive disorder
por: Chebli, H., et al.
Publicado: (2023)

Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder
por: Wu, Zhonghao, et al.
Publicado: (2022)

Structural neuroimaging differentiates between depressed bipolar disorder and major depressive disorder patients: a machine learning study
por: Calesella, F., et al.
Publicado: (2023)

The Metabolome-Wide Signature of Major Depressive Disorder
por: Jansen, Rick, et al.
Publicado: (2023)

Temperament and major depressive disorder
por: Karam, Elie G, et al.
Publicado: (2010)

Care pathways for people with major depressive disorder
por: Strawbridge, R., et al.
Publicado: (2022)

Clinical correlates of stress, immune and metabolic markers in major depression
por: Soria, V.
Publicado: (2023)

Effect of medical education on European psychiatrists’ knowledge in management of major depressive disorder and psychiatric emergencies
por: Thevathasan, L., et al.
Publicado: (2022)

The particularities of microangiopathic and macroangiopathic complications in type 2 diabetes mellitus patients correlated with the presence or absence of type D personality
por: Kalinovic, R., et al.
Publicado: (2021)

The level of depressive, anxiety and obsessive-compulsive psychopathological dimensions in symptomatic versus asymptomatic SARS-CoV-2 infected pregnant women
por: Enatescu, V.R., et al.
Publicado: (2022)

Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and Adolescents
por: Jiang, Yuanliang, et al.
Publicado: (2022)

The effect of childhood trauma and trauma-focused psychotherapy on blood expression in patients with major depressive disorder
por: Minelli, A., et al.
Publicado: (2021)

Linked patterns of symptoms and cognition with brain controllability in major depressive disorder
por: Li, Q., et al.
Publicado: (2023)

Signatures of HIV and Major Depressive Disorder in the Plasma Microbiome
por: Taylor, Bryn C., et al.
Publicado: (2023)

Endophenotypic markers of bipolar disorder (BD) in probands and their first degree relatives with major depression (MD)
por: Christodoulou, Anastasia Tessa
Publicado: (2010)

Pro-inflammatory markers predict response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
por: Husain, M. I., et al.
Publicado: (2023)

Model-based and model-free decision making in major depressive disorder after performing behavioral training
por: Bampi, A., et al.
Publicado: (2022)

Telomere attrition and inflammatory load in major depressive disorder
por: Squassina, A.
Publicado: (2021)

Probiotics as a therapeutic strategy in Major Depressive Disorder
por: Vargas, L.
Publicado: (2022)

Major depressive disorder with anxious features - the role of pregabalin
por: Carvalho, R. S., et al.
Publicado: (2023)

Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder
por: Bartova, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7qs5e64r9apb525lged0e4icjj